INO stock is dropping on news that its Covid-19 vaccine candidate is falling behind more established candidates. But science says there may still be a chance.

1 Key Thing You Might Be Overlooking With Inovio

06:08am, Thursday, 27'th Aug 2020
The biotech's coronavirus vaccine candidate gets the spotlight, but you might want to shine some light on this program, too.
Although Inovio shares have skyrocketed this year as part of the vaccine development efforts, the momentum in INO stock may not not be strong. The post Inovio Shares Have Been Hot in 2020 but Watch f
The pharmaceutical company remains a step behind coronavirus vaccine leaders -- in funding and in the clinical trial timeline.
INO is up over 300% year-to-date despite the recent sell off. INO-4800 got out of the blocks quickly, but the pace of development has faded a little.
INO stock is putting vaccine news front and center -- in place of strong fundamentals. If you decide to take a chance, be aware -- it's a specuative on The post Inovio Stock Is a Sideshow, Not a Serio
These are the top stocks to buy based on the 2020 U.S. presidential election, with new stock picks updated daily from the sharpest investing minds in the business.
Even a vaccine that's 50% effective with some side effects would be a game changer. The Trump Administration is throwing billions into that hope and investors are seeing big profits.
Reports of an early approval for AstraZeneca's COVID-19 vaccine are sending these three stocks lower today.

3 Coronavirus Stocks to Go on the Defensive

06:05am, Monday, 24'th Aug 2020
The pandemic shows no signs of slowing, it's time to use any signs of weakness in coronavirus stocks as a buying opportunity. The post 3 Coronavirus Stocks to Go on the Defensive appeared first on In
Here's exactly how they could realistically pull it off.

Inovio Becomes a Covid-19 Longshot

11:11am, Thursday, 20'th Aug 2020
No one knows which of the many vaccine candidates will be safe and effective, but Inovio's unique approach has left it without a major manufacturing contract. The post Inovio Becomes a Covid-19 Longs
Encouraging preliminary results for its Covid-19 vaccine and its budding HPV solutions make INO stock a great bet at this stage. The post Inovio Pharmaceuticals Stock Isn’t Just a Solid Covid-19 Pl

COVID-19: The Real Results Are A Long Way Away

03:47pm, Wednesday, 19'th Aug 2020
Hope for a successful vaccine by the winter is fueling trials at a record pace.
CureVac (NASDAQ: CVAC) held its initial public offering (IPO) on the Nasdaq stock exchange last week. CureVac expected the IPO share price would be between $14 and $16. Here's what you'll want to k
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE